The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-(4-(4'-(2-hydroxypropan-2-yl)-[1,1'-biphenyl]-4-yl)piperazin-1-yl)-9H-purin-9-yl)-tetrahydrofuran-3,4-diol ID: ALA4566815
PubChem CID: 155543567
Max Phase: Preclinical
Molecular Formula: C29H34N6O5
Molecular Weight: 546.63
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(O)c1ccc(-c2ccc(N3CCN(c4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)CC3)cc2)cc1
Standard InChI: InChI=1S/C29H34N6O5/c1-29(2,39)20-7-3-18(4-8-20)19-5-9-21(10-6-19)33-11-13-34(14-12-33)26-23-27(31-16-30-26)35(17-32-23)28-25(38)24(37)22(15-36)40-28/h3-10,16-17,22,24-25,28,36-39H,11-15H2,1-2H3/t22-,24-,25-,28-/m1/s1
Standard InChI Key: SNEFWXMHHMDRJR-ZYWWQZICSA-N
Molfile:
RDKit 2D
40 45 0 0 0 0 0 0 0 0999 V2000
34.9071 -11.0982 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.9177 -9.7747 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.4347 -10.4328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6950 -10.0348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6818 -10.8565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3829 -11.2765 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.1017 -10.8793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1149 -10.0577 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.4094 -9.6331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4214 -8.8160 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.1420 -8.4196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1559 -7.6061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4561 -7.1833 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.7407 -7.5802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7250 -8.3999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6443 -11.8758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8644 -12.1196 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.8551 -12.9367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6295 -13.1980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1171 -12.5423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9343 -12.5515 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.8733 -13.9780 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.1886 -13.4096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4459 -13.0688 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.4695 -6.3676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1863 -5.9728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2017 -5.1565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5012 -4.7341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7836 -5.1339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7717 -5.9489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5164 -3.9198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2326 -3.5241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2470 -2.7078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5458 -2.2863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8288 -2.6870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8180 -3.5020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5588 -1.4692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2729 -1.0718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8576 -1.0494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5507 -0.6480 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 5 1 0
4 2 1 0
2 3 2 0
3 1 1 0
4 5 2 0
4 9 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 1 0
10 15 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 16 1 0
16 1 1 1
20 21 1 6
19 22 1 6
18 23 1 1
23 24 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 25 1 0
13 25 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 35 1 0
35 36 2 0
36 31 1 0
28 31 1 0
34 37 1 0
37 38 1 0
37 39 1 0
37 40 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 546.63Molecular Weight (Monoisotopic): 546.2591AlogP: 1.66#Rotatable Bonds: 6Polar Surface Area: 140.23Molecular Species: NEUTRALHBA: 11HBD: 4#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.45CX Basic pKa: 4.53CX LogP: 2.16CX LogD: 2.16Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.28Np Likeness Score: 0.13
References 1. Crespo RA, Dang Q, Zhou NE, Guthrie LM, Snavely TC, Dong W, Loesch KA, Suzuki T, You L, Wang W, O'Malley T, Parish T, Olsen DB, Sacchettini JC.. (2019) Structure-Guided Drug Design of 6-Substituted Adenosine Analogues as Potent Inhibitors of Mycobacterium tuberculosis Adenosine Kinase., 62 (9): [PMID:31002508 ] [10.1021/acs.jmedchem.9b00020 ]